Merck KGaA at Festival of Biologics 2026
Oct 13–15, 2026 Basel, Switzerland ~3k attendees Website
Merck KGaA takes part in 6 sessions at Festival of Biologics 2026 in Basel. Its program centres on engineered antibodies that steer the immune system, including bispecifics that mimic the immune signal IL-12 and single-domain antibodies that kill cells carrying high levels of HER2. It also covers continuous purification and a squalene vaccine ingredient made by fermentation instead of from animals.
| Organization | Festival of Biologics 2026 Attendance |
|---|---|
Merck KGaA Darmstadt, Germany | |
German science and technology company in healthcare, life science (including bioprocessing products) and electronics. | Chair Tue Oct 13 16:45 Talk Tue Oct 13 17:30 Talk Wed Oct 14 11:50 Talk Wed Oct 14 14:10 Talk Wed Oct 14 14:10 |
Instantly find 20 buyers from Merck KGaA
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by Terrapinn or the Festival of Biologics. Submit a correction